Ken Griffin Astrazeneca PLC Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Astrazeneca PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 2,692,600 shares of AZN stock, worth $198 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,692,600
Previous 1,294,300
108.04%
Holding current value
$198 Million
Previous $101 Million
74.93%
% of portfolio
0.03%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...